Is there a need for early detection programs for chronic kidney disease?

Clinical Nephrology

Volumn 74, Issue SUPPL.1, 2010, Pages

  Katz, I J ^a,b   Gerntholtz, T E ^a   van Deventer, M ^c   Schneider, H ^e   Naicker, S ^d  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c Department of Clinical Chemistry ^*  (South Africa)

^d UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^e UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Chronic diseases; Diabetes; HIV; Hypertension; Non communicable diseases; Primary healthcare

Indexed keywords

ARTICLE; CHRONIC DISEASE; COST BENEFIT ANALYSIS; EARLY DIAGNOSIS; ECONOMICS; HUMAN; KIDNEY DISEASE; MASS SCREENING; METHODOLOGY;

CHRONIC DISEASE; COST-BENEFIT ANALYSIS; EARLY DIAGNOSIS; HUMANS; KIDNEY DISEASES; MASS SCREENING;

EID: 79952276492     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J et al. Kidney Disease as a Risk Factor for Development of Cardiovascular Disease:AStatement from the American Heart Association Councils on kidney in cardiovascular disease, High blood pressure research, clinical cardiology, and epidemiology and prevention. Hypertension. 2003; 42: 1050-1065.
2. Krzesinski J-M, Sumaili KE, Cohen E. How to tackle the avalanche of chronic kidney disease in sub-Saharan Africa: the situation in the Democratic Republic of Congo as an example. Nephrol Dial Transplant. 2007; 22: 332-335.
3. Moosa MR, Kidd M. The dangers of rationing dialysis treatment: The dilemma facing a developing country. Kidney Int. 2006; 70: 1107-1114.
4. Bachmann MO. Health Services Research. In: R JGaE (ed). Epidemiology: AResearch Manual for South Africa 2e. Oxford University Press: Cape Town, 2007, p 306-317.
5. Levey AS, Coresh J, Balk E, Kausz AT et al. National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification.AnnInternMed. 2003; 139: 137-147.
6. Schoolwerth AC, Engelgau MM, Hostetter TH, Rufo KH et al. Chronic kidney disease: a public health problem that needs a public health action plan. Prev Chronic Dis [serial online]. 2006.
7. Katz IJ, Schneider H, Shezia Z, Mdlelenia G et al. Managing type 2 diabetes in Soweto-The South African Chronic Disease Outreach Program experience. Primary Care Diabetes. 2009; 3: 157-164.
8. Sumaili EK, Krzesinski J-M, Zinga CV, Cohen EP et al. Prevalence of chronic kidney disease in Kinshasa: results of a pilot study from the Democratic Republic of Congo. Nephrol Dial Transplant. 2009; 24: 117-122.
9. Sumaili E, Cohen E, Zinga C, Krzesinski J-M et al. High prevalence of undiagnosed chronic kidney disease among at-risk population inKinshasa, theDem-ocratic Republic of Congo.BMCNephrology. 2009; 10: 18.
10. Obrador GT, Garcia-GarciaG,Villa AR, Rubilar X et al. Prevalence of chronic kidney disease in the Kidney Early Evaluation Program (KEEP) Mexico and comparison with KEEP US. Kidney Int. 2010; 77: 2-8.
11. de Jong PE, Hillege HL, Pinto-Sietsma SJ, de Zeeuw D. Screening for microalbuminuria in the general population: a tool to detect subjects at risk for progressive renal failure in an early phase? Nephrol Dial Transplant. 2003; 18: 10-13.
12. Hoy WE, McDonald S. Albuminuria: Marker or target in indigenous populations. Kidney Int. 2004; 66: 25-31.
13. Couper ID. Further reflections on chronic illness care. SA Fam Pract. 2007; 49: 4-10.
14. Mathew T, Corso O. Review article: Early detection of chronic kidney disease in Australia: Which way to go? Nephrology. 2009; 14: 367-373.
15. Mani MK. Nephrologists sans frontières: Preventing chronic kidney disease on a shoestring. Kidney Int. 2006; 70: 821-823.
16. Mani MK. Experience with a program for prevention of chronic renal failure in India. Kidney Int. 2005; 67: 75-78.
17. Mani MK. Nephrologists sans frontières: Preventing chronic kidney disease on a shoestring. Kidney Int. 2006; 70: 821-823.
18. van der Velde M, de Jong PE, Gansevoort RT. Comparison of the yield of different screening approaches to detect chronic kidney disease. Nephrol Dial Transplant. 2010; gfq156.
19. International Society of Nephrology: Program for detection and management of chronic kidney disease, hypertension, diabetes, and cardiovascular disease in developing countries (KHDC). In:Atkins R, Codreanu I, Peng L, Remuzzi G. (eds.) for the ISN COMGAN Research Committee. Brussels: International Society of Nephrology; 2005.
20. Hallan SI, Dahl Kl, Oien CM, Grootendorst DC et al. Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey. BMJ. 2006; 333: 1047.
21. Hoy WE,Wang Z, Baker PR, Kelly AM. Secondary Prevention of Renal and Cardiovascular Disease: Results of a Renal and Cardiovascular Treatment Program in an Australian Aboriginal Community. J Am Soc Nephrol. 2003; 14: 178-185.
22. Rossert JA, Wauters JP. Recommendations for the screening and management of patients with chronic kidney disease. Nephrol Dial Transplant. 2002; 17: 19-28.
23. de Jong PE, Brenner BM. From secondary to primary prevention of progressive renal disease: The case for screening for albuminuria. Kidney Int. 2004; 66: 2109-2118.
24. Ohmit SE, Flack JM, Peters RM, Brown WW et al. Longitudinal Study of the National Kidney Foundation's (NKF) Kidney Early Evaluation Program (KEEP). J Am Soc Nephrol. 2003; 14: 117-121.
25. Perico N, Plata R, Anabaya A, Codreanu I et al. Strategies for national health care systems in emerging countries: the case of screening and prevention of renal disease progression in Bolivia. Kidney Int. 2005; 97: 87-94.
26. Perico N, Bravo RF, De Leon FR, Remuzzi G. Screening for chronic kidney disease in emerging countries: feasibility and hurdles. Nephrol Dial Transplant. 2009; 24: 1355-1358.
27. Lei HH, Perneger TV, Klag MJ, Whelton PK et al. Familial aggregation of renal disease in a population-based case-control study. J Am Soc Nephrol. 1998; 9: 1270-1276.
28. Katz IJ, Hoy W, Kondalsamy-Chennakesavan S, Gerntholtz T et al. Chronic kidney disease management - what can we learn from South African and Australian efforts? Blood Purif. 2006; 24: 115-122.
29. Hoy WE, Scheppingen J, McKendry K, Sharma S et al. Planning Services for noncommunicable chronic disease (NCDs) in Aboriginal communities. In: (EDTA-ERA) EDaTA-ERA (ed). World Conference of Nephrology, Abstract, ISN EDTA-ERAWCN Berlin, 2003.
30. de Jong PE, van der Velde M, Gansevoort RT, Zoccali C. Screening for Chronic Kidney Disease: Where Does Europe Go? Clin J Am Soc Nephrol. 2008; 3: 616-623.
31. Hillege HL, Janssen WMT, Bak AAA, Diercks GFH et al. Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity. J Internal Med. 2001; 249: 519-526.
32. Hoy WE, Baker PRA, Kelly AM,Wang Z. Reducing premature death and renal failure in Australian Aboriginals. A community-based cardiovascular and renal protective program. Med J Aust. 2000; 172: 473-478.
33. Atthobari J, Asselbergs FW, Boersma C, de Vries R et al. Cost-effectiveness of screening for albuminuria with subsequent treatment with an ACEinhibitor to prevent cardiovascular events: Apharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of renal and vascular endstage disease intervention trial (PREVEND IT). Clinical Therapeutics. 2006; 28: 432-444